52 Week HighDivis Labs has hit a 52wk high of Rs 1,452.35 on NSE
52 Week HighDivis Labs has hit a 52wk high of Rs 1,445.00 on BSE
52 Week HighDivis Labs has hit a 52wk high of Rs 1,435.00 on BSE
52 Week HighDivis Labs has hit a 52wk high of Rs 1,430.00 on BSE
52 Week HighDivis Labs has hit a 52wk high of Rs 1,409.90 on NSE
52 Week HighDivis Labs has hit a 52wk high of Rs 1,398.00 on NSE
|Company Name||Last Price||%
|Dr Reddys Labs||2726.25||-3.59||2939.80||1786.50||46,375.93|
|Dec' 13||Sep' 13||Jun' 13||Mar' 13|
|Scheme||No. of Shares|
|Reliance Equity Opportunities Fund - Retail Plan (G)||2,630,734|
|Reliance Growth Fund - Retail Plan (G)||1,477,536|
|Reliance Regular Savings Fund - Equity Option (G)||858,733|
|SBI Emerging Businesses Fund (G)||643,338|
Divis Labs is in the Pharmaceuticals sector. The current market capitalisation stands at Rs 18,456.70 crore.The company has reported a consolidated sales of Rs 655.83 crore and a Net Profit of Rs 180.57 crore for the quarter ended Mar 2013.
The company management includes Murali K Divi - Chairman & Managing Director, N V Ramana - Executive Director, Madhusudana Rao Divi - Director - Projects, Kiran S Divi - President & Director, K Satyanarayana - Director, S Vasudev - Director, G Suresh Kumar - Director.
It is listed on the BSE with a BSE Code of 532488 and the NSE with an NSE Code of DIVISLAB.
Its Registered office is at 7-1-77/E/1/303, Divi Towers,,Dharam Karan Road, Hyderabad,Andhra Pradesh - 500016.
Their Registrars are Karvy Computershare Private Ltd.